Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLOBAL LONGLIFE HOSPITAL AND RESEARCH LTD.

NSE : NABSE : 543520ISIN CODE : INE0J2K01014Industry : Hospital & Healthcare ServicesHouse : Private

BSE19.601.4 (+7.69 %)

PREV CLOSE ( ) 18.20

OPEN PRICE ( ) 18.21

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 249000

TODAY'S LOW / HIGH ( )18.21 19.99

52 WK LOW / HIGH ( ) 15.4935.5

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-01 2012

Management Info

- Chairman Dhruv Sureshkumar Jani - Managing Director

Registered Office

Address 703, Sankalp Square,3b, Beside Taj Skyline,Sindhu Bhavan Road,
Ahmedabad,
Gujarat-380059

Phone 079 29708041 / 42 / 43 / 7211104280

Email investor@globalhospital.co.in

Website www.globalhospital.co.in

Registrars Details

Bigshare Services Pvt Ltd

E-2/3, Ansa Industrial Estate,Saki Vihar Road,Saki Naka,Mumbai

Listing : BSE

NEWS

14Jul Global Longlife Hospital and Research
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..

23Apr Global Longlife Hospital and Research
Global Longlife Hospital and Research has informed that pursuant to Regu..

19Oct Global Longlife Hospital and Research
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..

05Jan Global Longlife Hospital and Research
Global Longlife Hospital and Research has informed about compliance cert..

05Jan Global Longlife Hospital and Research
Global Longlife Hospital and Research has informed that there is no spec..

Financials

Rs. in Millions

	QTR	ANNUAL 25
Net Profit		1.98
Gross Profit		0.99
Operating Profit		8.57
Net Sales		5.77

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 5425.70 (2.09%)	M.Cap ( in Cr)2622.15
HealthcareGlobal (BSE) 710.65 (1.72%)	M.Cap ( in Cr)10020.71
RainbowChildrenS Med (BSE) 1362.05 (0.71%)	M.Cap ( in Cr)13832.86
Jupiter Life Line (BSE) 1414.95 (0.67%)	M.Cap ( in Cr)9277.26
Dr. Agarwal's Health (BSE) 491.25 (1.25%)	M.Cap ( in Cr)15531.89

Shareholding Pattern

	PROMOTERS	55.1%
	NON-INSTITUTION	44.9%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

GLOBAL LONGLIFE HOSPITAL AND RESEARCH LTD.